Comparative Pharmacology
Head-to-head clinical analysis: SULFAIR 15 versus SULFAIR FORTE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: SULFAIR 15 versus SULFAIR FORTE.
SULFAIR-15 vs SULFAIR FORTE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Sulfadoxine is a long-acting sulfonamide that inhibits dihydropteroate synthase, blocking folate synthesis. Pyrimethamine inhibits dihydrofolate reductase, synergistically inhibiting nucleic acid synthesis in Plasmodium species.
Folate antagonist; inhibits dihydropteroate synthetase in bacterial folate synthesis pathway.
15 mg orally every 6 hours, not to exceed 60 mg/day.
1-2 tablets (sulfamethoxazole 400 mg/trimethoprim 80 mg per tablet) orally every 12 hours.
None Documented
None Documented
12–15 hours in healthy adults; prolonged to 20–30 hours in moderate hepatic impairment.
Approximately 10-12 hours in patients with normal renal function; prolonged in renal impairment (up to 20-30 hours), necessitating dose adjustment.
Renal excretion unchanged: 70%; hepatic metabolism to inactive metabolites: 20%; fecal excretion: 10%.
Primarily renal excretion of unchanged drug (approx. 70-80%) and glucuronide conjugates; biliary excretion accounts for less than 20%; fecal elimination minimal.
Category C
Category C
Antibiotic (Sulfonamide)
Antibiotic (Sulfonamide)